These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 36465607)

  • 1. Gut microbiota is correlated with gastrointestinal adverse events of metformin in patients with type 2 diabetes.
    Huang Y; Lou X; Jiang C; Ji X; Tao X; Sun J; Bao Z
    Front Endocrinol (Lausanne); 2022; 13():1044030. PubMed ID: 36465607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclocarya paliurus polysaccharides alleviate type 2 diabetic symptoms by modulating gut microbiota and short-chain fatty acids.
    Yao Y; Yan L; Chen H; Wu N; Wang W; Wang D
    Phytomedicine; 2020 Oct; 77():153268. PubMed ID: 32663709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut.
    de la Cuesta-Zuluaga J; Mueller NT; Corrales-Agudelo V; Velásquez-Mejía EP; Carmona JA; Abad JM; Escobar JS
    Diabetes Care; 2017 Jan; 40(1):54-62. PubMed ID: 27999002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Dietary Fibre in Modulating Gut Microbiota Dysbiosis in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
    Ojo O; Feng QQ; Ojo OO; Wang XH
    Nutrients; 2020 Oct; 12(11):. PubMed ID: 33113929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota dysbiosis and decreased levels of acetic and propionic acid participate in glucocorticoid-induced glycolipid metabolism disorder.
    Zhang Q; Guan G; Liu J; Hu W; Jin P
    mBio; 2024 Feb; 15(2):e0294323. PubMed ID: 38226811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Composite probiotics alleviate type 2 diabetes by regulating intestinal microbiota and inducing GLP-1 secretion in db/db mice.
    Wang Y; Dilidaxi D; Wu Y; Sailike J; Sun X; Nabi XH
    Biomed Pharmacother; 2020 May; 125():109914. PubMed ID: 32035395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive Probio-X Treatment Enhances the Therapeutic Effect of a Conventional Drug in Managing Type 2 Diabetes Mellitus by Promoting Short-Chain Fatty Acid-Producing Bacteria and Bile Acid Pathways.
    Chen Y; Shen X; Ma T; Yu X; Kwok LY; Li Y; Sun Z; Li D; Zhang H
    mSystems; 2023 Feb; 8(1):e0130022. PubMed ID: 36688679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential mechanism of Liu-Wei-Di-Huang Pills in treatment of type 2 diabetic mellitus: from gut microbiota to short-chain fatty acids metabolism.
    Yi ZY; Chen L; Wang Y; He D; Zhao D; Zhang SH; Yu R; Huang JH
    Acta Diabetol; 2022 Oct; 59(10):1295-1308. PubMed ID: 35857109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achyranthes bidentata polysaccharide ameliorates type 2 diabetes mellitus by gut microbiota-derived short-chain fatty acids-induced activation of the GLP-1/GLP-1R/cAMP/PKA/CREB/INS pathway.
    Xia T; He W; Luo Z; Wang K; Tan X
    Int J Biol Macromol; 2024 Jun; 270(Pt 2):132256. PubMed ID: 38729481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study.
    Bryrup T; Thomsen CW; Kern T; Allin KH; Brandslund I; Jørgensen NR; Vestergaard H; Hansen T; Hansen TH; Pedersen O; Nielsen T
    Diabetologia; 2019 Jun; 62(6):1024-1035. PubMed ID: 30904939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects.
    Rohde U
    Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
    Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
    Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRM1201 effectively inhibits colorectal cancer metastasis via shaping gut microbiota and short- chain fatty acids.
    Jia R; Shao S; Zhang P; Yuan Y; Rong W; An Z; Lv S; Feng Y; Liu N; Feng Q; Wang Y; Li Q
    Phytomedicine; 2024 Sep; 132():155795. PubMed ID: 38878524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive relationships between gut microbiome and faecal metabolome in individuals with type 2 diabetes and its complications.
    Zhao L; Lou H; Peng Y; Chen S; Zhang Y; Li X
    Endocrine; 2019 Dec; 66(3):526-537. PubMed ID: 31591683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kazak faecal microbiota transplantation induces short-chain fatty acids that promote glucagon-like peptide-1 secretion by regulating gut microbiota in
    Han X; Wang Y; Zhang P; Zhu M; Li L; Mao X; Sha X; Li L
    Pharm Biol; 2021 Dec; 59(1):1077-1087. PubMed ID: 34392792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 16S rRNA Sequencing and Metagenomics Study of Gut Microbiota: Implications of BDB on Type 2 Diabetes Mellitus.
    Zhang L; Luo J; Li X; Guo S; Shi D
    Mar Drugs; 2020 Sep; 18(9):. PubMed ID: 32957565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of berberine and metformin on intestinal inflammation and gut microbiome composition in db/db mice.
    Zhang W; Xu JH; Yu T; Chen QK
    Biomed Pharmacother; 2019 Oct; 118():109131. PubMed ID: 31545226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity.
    Remely M; Aumueller E; Merold C; Dworzak S; Hippe B; Zanner J; Pointner A; Brath H; Haslberger AG
    Gene; 2014 Mar; 537(1):85-92. PubMed ID: 24325907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of Dietary Intake with the Intestinal Microbiota and Short-Chain Fatty Acids Among Young Adults with Type 1 Diabetes and Overweight or Obesity.
    Igudesman D; Crandell JL; Corbin KD; Hooper J; Thomas JM; Bulik CM; Pence BW; Pratley RE; Kosorok MR; Maahs DM; Carroll IM; Mayer-Davis EJ
    J Nutr; 2023 Apr; 153(4):1178-1188. PubMed ID: 36841667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imbalance of Microbacterial Diversity Is Associated with Functional Prognosis of Stroke.
    Zhang X; Wang X; Zhao H; Cao R; Dang Y; Yu B
    Neural Plast; 2023; 2023():6297653. PubMed ID: 37197229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.